Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
29.65
+1.31 (4.62%)
At close: Mar 9, 2026, 4:00 PM EDT
29.98
+0.33 (1.11%)
After-hours: Mar 9, 2026, 5:26 PM EDT
Viridian Therapeutics Market Cap
Viridian Therapeutics has a market cap or net worth of $3.03 billion as of March 9, 2026. Its market cap has increased by 130.19% in one year.
Market Cap
3.03B
Enterprise Value
2.21B
1-Year Change
130.19%
Ranking
Category
Stock Price
$29.65
Market Cap Chart
Since June 18, 2014, Viridian Therapeutics's market cap has increased from $34.70M to $3.03B, an increase of 8,633.21%. That is a compound annual growth rate of 46.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.90B | -2.48% |
| Dec 31, 2025 | 2.97B | 95.60% |
| Dec 31, 2024 | 1.52B | 32.59% |
| Dec 29, 2023 | 1.15B | -2.59% |
| Dec 30, 2022 | 1.18B | 173.74% |
| Dec 31, 2021 | 429.50M | 567.96% |
| Dec 31, 2020 | 64.30M | 320.26% |
| Dec 31, 2019 | 15.30M | -83.62% |
| Dec 31, 2018 | 93.40M | -59.86% |
| Dec 29, 2017 | 232.70M | 6,363.89% |
| Dec 30, 2016 | 3.60M | -55.00% |
| Dec 31, 2015 | 8.00M | -16.67% |
| Dec 31, 2014 | 9.60M | -72.33% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spyre Therapeutics | 3.15B |
| Denali Therapeutics | 3.12B |
| Tarsus Pharmaceuticals | 3.12B |
| Edgewise Therapeutics | 2.98B |
| Arcutis Biotherapeutics | 2.98B |
| Catalyst Pharmaceuticals | 2.96B |
| IDEAYA Biosciences | 2.91B |
| Dianthus Therapeutics | 2.82B |